Michael Ison, MD MS Profile Banner
Michael Ison, MD MS Profile
Michael Ison, MD MS

@MichaelGIsonMD

Followers
4,822
Following
2,221
Media
824
Statuses
8,081

#TxID MD and clinical respiratory virologist & Editor-in-Chief @TheTxIDjournal . All opinions and tweets are my own.

Rockville, MD
Joined June 2020
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@MichaelGIsonMD
Michael Ison, MD MS
2 years
🚨Big Personal News🚨 After 17 years at Northwestern, I will be leaving to take a new role at the NIH (Respiratory Disease Branch Chief). As you can imagine, it was a difficult decision.
127
17
825
@MichaelGIsonMD
Michael Ison, MD MS
3 years
We have our first COVID-19 breakthrough despite Evusheld. We definitely need approaches to collect this data in real time as it may inform efficacy of this new preventative therapy.
22
69
324
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Day 1 down - lots of new systems to learn but energized to be at NIH!
Tweet media one
9
3
305
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Time to get my badge and start the next phase of my career.
Tweet media one
16
0
276
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Today was my last clinic - for the last 17 years (nearly 900 clinics), I’ve had the honor of caring for countless patients - getting them ready for transplant and caring for them after.
8
2
272
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Look at hospitals - 100% mask mandate that is actually enforced. Also a place with many high risk patients and always indoor. No reports of outbreaks and data from ours and other hospitals suggest most cases in employees were of community origin.
@DrTomFrieden
Dr. Tom Frieden
4 years
Places around the world that used masks consistently have had half to two-thirds less Covid spread. Imagine how many deaths could have been prevented in the US if the federal government had focused on masks rather than hydroxychloroquine.
618
6K
20K
6
66
226
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Honored to be selected to be the next editor-in-chief of @TheTxIDjournal . So thankful to Bob Rubin, Hans Hirsch and @FranciscoMarty_ for their incredible leadership to establish this critical journal for our community.
Tweet media one
29
17
232
@MichaelGIsonMD
Michael Ison, MD MS
2 years
So as we see more and more rebound after Paxlovid, some with documented transmissions after the rebound, and @pfizer reporting ~$22B in profit - what is being done to understand and correct the issue? How often does it happen? Do we need longer therapy or combos?
10
50
176
@MichaelGIsonMD
Michael Ison, MD MS
2 years
My view for the last 17 years - coming to an end in 21 days!
Tweet media one
12
1
150
@MichaelGIsonMD
Michael Ison, MD MS
2 months
Such an AMAZING honor - thanks to all who got me to where I am! @NM_Transplant
@AST_IDCOP
Infectious Diseases Community of Practice - AST
2 months
🎉Congratulations to @AST_IDCOP legend and leader @MichaelGIsonMD , who is the winner of the @AST_info Senior Achievement Award in Clinical Transplantation. We are so thankful for your service and leadership in #TxID !! #ATC2024Philly 🍾
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
11
76
26
9
148
@MichaelGIsonMD
Michael Ison, MD MS
1 year
It was a huge honor to receive the Bob Rubin Award! You kind words as part of the nomination were so touching!
@mahalamri
Maha al amri
1 year
A very well deserved award to an exceptional mentor @MichaelGIsonMD No words can describe the dedication and support you gives to your mentees. You set an example of what mentorship and leadership.I am lucky to be handed my transplant ID certificate by a legend like you #ATC2023
Tweet media one
Tweet media two
Tweet media three
2
6
50
21
2
146
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Cleaning my office at Maria wanted to take a picture of all my saved lanyards!
Tweet media one
1
1
137
@MichaelGIsonMD
Michael Ison, MD MS
2 years
17+ years, countless trainees, thousands of patients cared for - it’s been an amazing time @NM_Transplant @NM_Lung @NM_IDSteward - thankful for a superstar last week of service with another dream team @mahalamri
Tweet media one
3
5
134
@MichaelGIsonMD
Michael Ison, MD MS
3 years
I am at a loss for word - I have known ⁦ @FranciscoMarty_ ⁩ since my #TxId in Boston. A kind, hardworking leader. Speaking with him just Friday he was excited to have some time off. The world and #TxID won’t be the same without him.
Tweet media one
3
9
132
@MichaelGIsonMD
Michael Ison, MD MS
1 year
An incredible day - RSV vaccine recommended by #ACIP for adults >60 and older should receive a single dose of one of the 2 approved vaccines! It is thrilling to see the potential improvement in quality and quantity of life that these vaccines will provide!
3
32
133
@MichaelGIsonMD
Michael Ison, MD MS
3 years
As we are on the cusp of authorization of a 3rd dose of #SARSCoV2 #Vaccine for immunocompromised, I think its time for the entire Transplant Community begin focusing on some important questions that this entire situation has brought up 1/X
6
36
132
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Understanding which agent to use against CREs in one slide - strong work @StephaniePouch ! @NM_Transplant @NM_IDSteward
Tweet media one
1
32
127
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Great summary of impact of various MAbs used in oncology and their infectious risks @monicaslavin #ECCMID2022
Tweet media one
1
30
128
@MichaelGIsonMD
Michael Ison, MD MS
2 months
Last night, my former colleague and @AST_info President @JoshLevitskyMD gave me the AST Senior Achievement Award in Clinical Transplantation - I have been incredibly luck to work w/ so many amazing individuals at AST, @UNOSNews , @NM_Transplant and @TheTxIDjournal over the yrs 1/X
Tweet media one
12
14
130
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Congratulations to @SajalTanna for her promotion to Assistant Professor in Infectious Diseases @NUFeinbergMed @NM_IDSteward !!!
Tweet media one
10
4
114
@MichaelGIsonMD
Michael Ison, MD MS
2 years
The data is clear - there is generally no need to treat asymptomatic bacteriuria.
@GermHunterMD
Ilan Schwartz MD PhD
2 years
In this single centre RCT from Mexico (n=80), treatment of asymptomatic bacteriuria in the first 2 months post-kidney transplant did not reduce the incidence of UTI or graft pyelonephritis #TxID
Tweet media one
10
71
197
4
17
108
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Absolutely incredible news! RSV has been a significant cause of hospitalization and death in older adults, very young and immunocompromised. The first approved vaccine with 94% efficacy against RSV-related lower respiratory tract disease. ⁦ @GSK
2
21
107
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Honor to speak as part of the press conference with @AnkitBharatMD and the rest of the @NorthwesternMed Lung Transplant Team about our first transplant in a COVID-19 patient
Tweet media one
5
17
103
@MichaelGIsonMD
Michael Ison, MD MS
3 years
#FluShotSelfie - I got mine! Protected against flu AND COVID-19! Ready for the winter!
Tweet media one
6
7
103
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Tocilizumab - another drug used extensively off label and was “the answer” has been shown not to reduce mortality, ordinal scale at week 4, or reduce ventilator days. Opinion and anecdotes shouldn’t be what drives care, even in pandemic.
5
27
99
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Excited to announce a new section for @TheTxIDjournal - entitled “Transplant ID Office Hours” - this section is going to transform some discussions by @TxID_Fellows into a permanent set of advice for fellows and jr faculty. Focusing on the next generation of TID!
6
14
98
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Honored to present about antiviral therapy for respiratory infections at the @fredhutch #IDSymp23 - for those who want the slides, they are available here.
10
16
97
@MichaelGIsonMD
Michael Ison, MD MS
1 year
It was a huge honor to work on this important study - the RSV vaccine adds to our armamentarium to keep our older adults safe from the scourge of this important pathogen. Thanks to the dedicated @NM_Transplant research team for their support.
5
19
94
@MichaelGIsonMD
Michael Ison, MD MS
2 years
After 26 months - my first international trip - looking forward to #ECCMID2022 and then on to #ISHLT2022
Tweet media one
0
0
95
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Thanks to the scientists, study teams and subjects for making this happen! Thanks to @US_FDA and @CDCgov for following the regs to ensure safety and effectiveness. Thanks to the hidden teams locally for making this happen seamlessly @NUFeinbergMed #IGotTheShot @NUCATSInstitute
Tweet media one
1
6
94
@MichaelGIsonMD
Michael Ison, MD MS
3 years
We’ve heard from several patients and confirmed with our social workers - @cvspharmacy and @Walgreens not have a process yet to give 4th doses to our transplant patients. This is totally unacceptable as the guidance has been in place for over a month and patients are coming due!
16
18
91
@MichaelGIsonMD
Michael Ison, MD MS
1 year
True highlight of my career - receiving the Bob Rubin award thanks to my amazing fellows for their kind words - it’s been such an honor to work with you and see you grow to become leaders in the field @mahalamri @MadyHeldman @HannahNamMD @rebecca_kumar @CA_Boutin @SajalTanna
Tweet media one
Tweet media two
Tweet media three
16
7
92
@MichaelGIsonMD
Michael Ison, MD MS
3 years
I am excited to announce that we have been approved for a Transplant ID Fellowship @NM_IDSteward ! More details will be coming soon. We already have the position filled for 2021-2022. @TStosor @mangarone23 @SajalTanna
8
7
90
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Looks like we are going to need a doubling of dose for Evusheld for all new patients and those who previously got it will need to be redosed. Thanks @dan_dkauld for flagging this!
6
38
87
@MichaelGIsonMD
Michael Ison, MD MS
1 year
I'm excited by the data supporting the FDA approve of letermovir. The real challenge is going to be the HUGE cost difference between valGCV and letermovir. Per GoodRx, generic valGCV is $155-$998 per month while letermovir is $6700 - $7700 per month.
2
15
88
@MichaelGIsonMD
Michael Ison, MD MS
2 years
As we finish packing the car and reflect on lots of goodbyes with friends and colleagues, I am thankful for for all of the love and well wishes. It makes me realize how lucky I am to have been surrounded by amazing people in every aspect of my life. Now on to the next adventure!
5
1
87
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Congrats @KottonNelson on the @AST_info Physician of Distinction Award
Tweet media one
4
8
85
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Absolutely amazing! For the first time ever, we have transplanted 40,000 patients - that is an incredible number! More lives saved, more lives improved - all during an incredibly challenging time! @NM_Transplant @UNOSNews @AST_IDCOP @TheTxIDjournal
Tweet media one
3
15
84
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Nothing beats a selfie cappuccino! #ICHS2022
Tweet media one
4
4
81
@MichaelGIsonMD
Michael Ison, MD MS
10 months
The highlight of meetings is the #TIDSupperClub - connecting with fellow #TxID colleagues to discuss work and life is key! Thanks Nicole Theodoropoulos for organizing @EmilyBlumbergMD @ArunaSubraman12 @PCH_SF @jschaenman @jobadd @maricar_malinis @amezochow @SajalTanna
Tweet media one
6
7
81
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Last - I’ll provide clinical recommendations based on summarized data from COVID-19 and placing in context with other vaccines @ATCMeeting @AST_IDCOP
Tweet media one
4
22
77
@MichaelGIsonMD
Michael Ison, MD MS
3 years
“Individual antibody levels, as measured by myriad commercial assays, do not offer a useful indicator as to whether a booster dose is needed; their use outside of clinical research should be discouraged.” Couldn’t agree more.
5
15
75
@MichaelGIsonMD
Michael Ison, MD MS
4 years
So proud of my incredible research team - we have enrolled our 100th COVID-19 recovered patient today! We will be able to better understand immune responses to infections and how long they last with this study. We have several special populations - first report under review!
2
1
71
@MichaelGIsonMD
Michael Ison, MD MS
11 months
A discovery that has totally transformed our approach to vaccines and allowed us to emerge quickly from the COVID-19 pandemic - can’t think of a more deserving award!
@WeissmanLab
The Drew Weissman Lab
11 months
!!!!!!!!
Tweet media one
169
927
8K
3
6
69
@MichaelGIsonMD
Michael Ison, MD MS
3 years
I encourage all in #TxID to mark their calendars and save the date for our First @TheTxIDjournal and TID Section of @ttsorg Clincaopathologic Conference. See if you can help the team figure out how to diagnose and manage a brain lesion in a transplant patient!
Tweet media one
6
22
69
@MichaelGIsonMD
Michael Ison, MD MS
4 years
COVID is being compared to Influenza again - To date, there are as many COVID-19 related deaths as nearly 5 years of influenza - and its only been 7 months with the disease.
Tweet media one
2
31
67
@MichaelGIsonMD
Michael Ison, MD MS
10 months
This is great news - we are going to be introducing new initiatives to facilitate people getting their papers published with @TheTxIDjournal - still without publication fees. @AST_IDCOP @TxID_Fellow @PergamIC @DocSaimaAslam @jaguadog1 @RazonableMD @MaddalenaPeghin @monicaslavin
@TheTxIDjournal
TransplantID Journal
10 months
@TheTxIDjournal is pleased to announce that we are now accepting papers rejected from other journals with expedited review. As opposed to some journals that charge over $3000/article, there is no publication fee @TheTxIDjournal .
Tweet media one
2
10
49
1
13
68
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Excited to see our 1st @TheTxIDjournal Special Edition focused on Antimicrobial Stewardship. Great work by @Gnfidz and @shahidh80523771 who are the guest editors.
2
25
66
@MichaelGIsonMD
Michael Ison, MD MS
2 years
As I reflect back on an amazing @IDWeek2022 , I’m exceptionally thankful for 3 things: 1. The amazing advances (including COVID vaccine that allowed the meeting to happen) in science that have given us the promise of new RSV vaccines and new drugs to treat a range of infxns.
1
2
65
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Fun things you find when you are starting to clean out your office - my first poster from fellowship (lots of what not to do) and my TID Fellowship Certificate!
Tweet media one
Tweet media two
6
0
66
@MichaelGIsonMD
Michael Ison, MD MS
2 years
My last @NorthwesternMed #FluSelfie ! If you haven’t gotten yours, with cases expanding rapidly, nows the time to get it!
Tweet media one
1
1
63
@MichaelGIsonMD
Michael Ison, MD MS
10 months
#FluShotSelfie - Thanks to the @NIHClinicalCntr Team for coming to vaccinate our office. It’s a good reminder - everyone should: ✅ Get your Flu Shot ✅ Get your 2023-2024 COVID-19 Shot ✅ Get your RSV vaccine if over 60 years of age
Tweet media one
3
3
65
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Finished my last Transplant Nurse Educational session - these nurses are nothing short of amazing - always positive, always putting patients first! ⁦ @NM_Transplant
Tweet media one
0
4
63
@MichaelGIsonMD
Michael Ison, MD MS
10 months
excited to see @EmilyBlumbergMD , @IDSAInfo Finland Lecturer for 2023, shining a light on #TxID - highlighting about our key role in expanding the donor pool. Given all that Emily has done & how many stars she’s trained - I cannot think of a more deserving awardee!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
2
62
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Congrats to @maricar_malinis who is going to take over as the lead of the @TheTxIDjournal / @ttsorg TID Section CPCs. Moving forward, @wan_clemente & @StephaniePouch will continue to work with Malinis on the CPC. A new member will be selected to help this superstars team soon.
Tweet media one
8
8
63
@MichaelGIsonMD
Michael Ison, MD MS
2 years
@davidvanduin will now present the 10 best SOT ID papers
Tweet media one
2
20
63
@MichaelGIsonMD
Michael Ison, MD MS
3 years
The @AST_IDCOP Virtual Meeting started with a reflection on Francisco Marty’s contribution to the field.
Tweet media one
2
2
61
@MichaelGIsonMD
Michael Ison, MD MS
1 year
This is one of the most educational and thought provoking podcasts I’ve listened to. Amazing review of molecular diagnostics and discussion of challenges in their use and application @febrilepodcast @micro_rp @AST_IDCOP
2
8
60
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Looking for an excellent review on infectious complications of kidney transplants? It was great working with @NU_Nephrology Abby Agrawal and @ldanzigerisakov on this review.
1
18
59
@MichaelGIsonMD
Michael Ison, MD MS
2 years
What can beat a true @NM_IDSteward dream team on my second to last week on @NM_Transplant TID Service (superstars: TID Fellow @mahalamri , TID PharmD @moore_wjustin and Chief Fellow @beckyosbornmd ? A delicious cake 🎂 at the end of rounds!
Tweet media one
Tweet media two
1
4
61
@MichaelGIsonMD
Michael Ison, MD MS
3 years
As we get more and more data on COVID Vax responses, we get a clearer picture of extent of protection. After 2 doses 87% of heart and 93% of liver recipients had humoral and/or cellular responses. @EmilyBlumbergMD @NATBASH15 @camwolfe @nikkitheomd
7
28
60
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Transplant Nurses are the core of organ transplantation - they are central to the success of every program and every patients. Thank you for all you do!
@ODTAlliance
Organ Donation and Transplantation Alliance
1 year
Transplant Nurses are a driving force in our collective mission to save and heal lives. Join us this #TransplantNursesWeek as we celebrate and honor their incredible work!
Tweet media one
0
7
16
4
9
58
@MichaelGIsonMD
Michael Ison, MD MS
2 months
Great session by Jay Fishman @mgh_id @mgh_transplant talking about the value of TID, why transplant-specific ID expertise is essential and the need to keep #TxID a core part of all Tx programs.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
9
61
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Tasty food, great conversation- this is what I’ve missed during the pandemic! Such a treat to catch up with @StephaniePouch and plot our the next steps for the @AST_IDCOP Controversy Conference!
Tweet media one
0
0
60
@MichaelGIsonMD
Michael Ison, MD MS
11 months
Looking forward to a great 2 day Update on Infections in the immunocompromised Host @IchsGlobal @ESCMID @esgrev_escmid Full Schedule and registration details at:
Tweet media one
1
24
60
@MichaelGIsonMD
Michael Ison, MD MS
2 years
A sign of both an amazing session and the popularity of #TxID - a packed room learning about Oncology/HSCT ID #ECCMID2022
Tweet media one
0
5
60
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Unsure of what to do about the SARS-CoV-2 vaccine for transplant patients? The @ttsorg TID section has updated guidelines for COVID-19 in this population! @wan_clemente @jobadd @FranciscoMarty_ @maricar_malinis
4
27
56
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Such a treat to get one last dinner with @mahalamri before she returns to Saudi Arabia - looking forward to a bright future of TxID after a super successful 2 years training at @NM_Transplant @NM_IDSteward ! @SajalTanna
Tweet media one
3
4
59
@MichaelGIsonMD
Michael Ison, MD MS
2 years
15 years of tireless leadership to establish and run the gold standard organ vigilance system - @UNOSNews DTAC and it’s leaders have accomplished so much. Thanks to @AST_info and @RicardoLaHozMD for organizing this reunion
Tweet media one
2
5
57
@MichaelGIsonMD
Michael Ison, MD MS
2 years
and to have the opportunity to train the future experts in our field. Overall, Ken and I are very much looking forward to our move to (and our new life together in) DC! Full details will follow soon.
19
0
55
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Tweet media one
7
8
58
@MichaelGIsonMD
Michael Ison, MD MS
4 years
Thanks - honored to take on this new leadership role - hope to make clinical research easier for all of us at @NorthwesternU
16
0
58
@MichaelGIsonMD
Michael Ison, MD MS
1 year
The excitement is almost too much to handle for tomorrow’s @fredhutch 4th Symposium on ID in ICH - already ran into @NATBASH15 , @ldanzigerisakov , @MadyHeldman , @AjitLimaye2 and Michael Boeckh!
2
4
55
@MichaelGIsonMD
Michael Ison, MD MS
4 months
Great NTM session by @van_jakko and Claire Andrejak - best proof we need better drugs and trials in humans to inform therapy. Our current therapies have significant challenges. @ESCMID Global. Current @NIAIDFunding NOSI around this issue:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
18
57
@MichaelGIsonMD
Michael Ison, MD MS
9 months
Not a bad place to talk about NTM Research
Tweet media one
3
0
56
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Congratulations to all members and collaborators of the @UNOSNews /OPTN Disease Transmission Advisory Committee in being honored for our contributions with the @AST_info Innovation Award! @EmilyBlumbergMD @camwolfe @ldanzigerisakov
Tweet media one
6
4
56
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Excited to announce the launch of our registry of Lung Transplants for COVID-19. This is a team effort from Rade Tomic and @MichaelGIsonMD from @NM_Lung @NM_IDSteward , @DocSaimaAslam and Max Weder @uvatransplant
4
15
54
@MichaelGIsonMD
Michael Ison, MD MS
10 months
Congratulations ⁦ @DocSaimaAslam ⁩ - newly elected member of the ⁦ @ISHLT ⁩ Board! So excited to see another superstar #TxID on the board! ⁦ @AST_IDCOP
Tweet media one
4
5
55
@MichaelGIsonMD
Michael Ison, MD MS
2 months
Ready for #ATC2024 day 2 - so loving the 7am session start time
Tweet media one
1
0
56
@MichaelGIsonMD
Michael Ison, MD MS
4 years
As a journal editor, it is increasingly challenging to get people to agree to review papers. Today, I caught up on a dozen reviews I accepted to do. If you have papers you want reviewed, agree to be a reviewer.
7
3
55
@MichaelGIsonMD
Michael Ison, MD MS
3 years
I want to send a big thanks to our @TheTxIDjournal Deputy Editors - @jaguadog1 , Andreas Groll, Monica Slavin, @PergamIC , @RazonableMD and @nikkitheomd . Our turn-around-times for decisions are AMAZING. Average turn around time to first decision sent to authors is 13 days!
Tweet media one
1
5
54
@MichaelGIsonMD
Michael Ison, MD MS
1 year
Congratulations to @CA_Boutin who got a travel award to @fredhutch #IDSymp23 to present our #NNITS (Nitazoxanide for Norovirus in Transplant Study) - transient symptomatic improvement but no change in other markers and doesn’t lead to cure. @NM_Transplant @nutorc
Tweet media one
3
7
54
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Congratulations to Daniela Ladner @nutorc , @NUFeinbergMed @Northwestern_Tx ! Through her hard work, she was awarded at T35 grant to support our incredibly successful NUCTORC Summer Research Program for Medical Students with the T35 program starting in 2022!!!
Tweet media one
4
4
55
@MichaelGIsonMD
Michael Ison, MD MS
3 years
There is a real problem with how Evusheld is being distributed. We’ve become aware that a private group (iCare Mobile) is offering the MAb to the public. Meanwhile, some large centers with huge populations of eligible patients still have not drug - @MoffittNews @UMiamiHealth
Tweet media one
8
28
53
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Our opinion piece highlights the overuse of antibiotics and underutilization of antivirals (that reduce need for antibiotics) in patients with flu. ⁦ @jeffreylinder ⁩ ⁦ @NM_IDSteward
0
14
54
@MichaelGIsonMD
Michael Ison, MD MS
6 months
Are you focused on Infections in Immunocompromised Hosts ( #TxID )? Are you a member of @ESCMID ? Make sure you are a member of ESGICH - its easy and free - just add the study group under your profile.
1
8
54
@MichaelGIsonMD
Michael Ison, MD MS
2 years
So excited to see the @TheTxIDjournal to have crossed the 4000 followers! Such amazing accomplishment in a little over a year! Strong work @PergamIC in leading our Twitter presence.
2
1
54
@MichaelGIsonMD
Michael Ison, MD MS
1 year
@GermHunterMD @AST_info holds its annual Fellow’s meeting in Texas - definitely time to rethink this longstanding tradition!
3
0
52
@MichaelGIsonMD
Michael Ison, MD MS
3 years
Excited to see the results of the SOLSTICE Maribavir trial published - this will help us as we begin to use this newly FDA-approved drug! @RobinRavery4 @BarbAlexanderMD @EmilyBlumbergMD @ChemalyRoy @dktransplant @KamarNassim @dfflorescu @GenPapaMD
Tweet media one
1
12
53
@MichaelGIsonMD
Michael Ison, MD MS
7 months
Excited to see this important data out. Adjuvanted RSV vaccine found to have efficacy over 2 seasons of 1 RSVPreF3 OA dose was 67.2% (97.5% CI: 48.2-80.0) against RSV-LRTD and 78.8% (95% CI: 52.6-92.0) against severe RSV-LRTD.
5
11
52
@MichaelGIsonMD
Michael Ison, MD MS
2 years
Beautiful walk into work - 5 more days!
Tweet media one
Tweet media two
1
2
51
@MichaelGIsonMD
Michael Ison, MD MS
4 years
What I currently hate about my life - the insane amount of time I'm on Zoom, Skype, WebEx and Teams meetings. My day started at 6am and the last call ended at 6pm. I had only about 1 hour spread throughout the day that was not on a virtual meeting.
2
1
51
@MichaelGIsonMD
Michael Ison, MD MS
4 years
What started as a small group of experts, has grown into the best organ vigilance program in the world! Review of data from its first 10 years is out! ⁦ @camwolfe ⁩ ⁦ @EmilyBlumbergMD ⁩ ⁦ @mg_michaels
1
17
52